Share Issue/Capital Change • Jun 27, 2023
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 9403D
SuperSeed Capital Limited
27 June 2023
SUPERSEED CAPITAL LIMITED
("SuperSeed" or the "Company")
Issuance of Investor Warrants to Broker to Aid Liquidity
SuperSeed Capital (AQSE: WWW), a company established as a venture capital fund of funds for early-stage artificial intelligence and software companies, is pleased to announce the issuance of investor warrants to its broker, VSA Capital plc ("VSA"), as a facility to aid liquidity in the market.
Under this arrangement, SuperSeed has authorized the issuance of 100,000 investor warrants to VSA at a price of £1.12 per warrant. The warrants will be exercisable for a period of 6 months from the date of issuance. The purpose of these warrants is to provide additional flexibility and liquidity to support the orderly trading of SuperSeed's shares.
By issuing these warrants to VSA, SuperSeed aims to enhance market efficiency and improve the overall liquidity of its shares.
The Company believes that this facility will enable a more active and liquid market for its securities, benefiting both existing shareholders and potential investors.
SuperSeed remains committed to creating value for its shareholders and will continue to explore opportunities that enhance liquidity, improve market conditions, and support the growth and development of the Company.
Following the issuance of the Warrants, SuperSeed has a total of 100,000 warrants in issue, representing approximately 4.06% of the enlarged share capital assuming full exercise of all warrants.
For more information, please contact:
| SuperSeed Capital Limited | +44(0)20 3405 3060 |
| Mads Jensen, Managing Partner | |
| VSA Capital - AQSE Corporate Adviser and Broker | +44(0)20 3005 5000 |
| Corporate Finance: Andrew Raca Corporate Broking: Andrew Monk, Peter Mattsson, David Scriven |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NEXFLFVSRFIRFIV
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.